findmyKOL
Clinical trialNCT04403139Active, not recruitingPhase 4Interventional

VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination

SponsorUniversity of WashingtonEnrollment50Varicella Zoster Virus Infection
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To evaluate the effect of intramuscular RZV vaccine on VZV-specific skin TRM and circulating T-cells
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Washington Virology Research Clinic

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Varicella zoster virus glycoprotein E
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 Apr 2022
Primary completion
31 Dec 2026
Completion
31 Dec 2026
Last update posted
5 May 2026
Registered enrollment
50
Registry id
NCT04403139
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.